BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 15371954)

  • 1. Neuroendocrine secretory protein-55 (NESP-55) expression discriminates pancreatic endocrine tumors and pheochromocytomas from gastrointestinal and pulmonary carcinoids.
    Srivastava A; Padilla O; Fischer-Colbrie R; Tischler AS; Dayal Y
    Am J Surg Pathol; 2004 Oct; 28(10):1371-8. PubMed ID: 15371954
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunohistochemical staining for CDX-2, PDX-1, NESP-55, and TTF-1 can help distinguish gastrointestinal carcinoid tumors from pancreatic endocrine and pulmonary carcinoid tumors.
    Srivastava A; Hornick JL
    Am J Surg Pathol; 2009 Apr; 33(4):626-32. PubMed ID: 19065104
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunohistochemical expression of neuroendocrine secretory protein-55 (NESP-55) in pituitary adenomas.
    Gupta M; Lloyd RV; Fischer-Colbrie R; Tischler AS; Dayal Y
    Endocr Pathol; 2011 Sep; 22(3):150-4. PubMed ID: 21584660
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NESP55, a novel chromogranin-like peptide, is expressed in endocrine tumours of the pancreas and adrenal medulla but not in ileal carcinoids.
    Jakobsen AM; Ahlman H; Kölby L; Abrahamsson J; Fischer-Colbrie R; Nilsson O
    Br J Cancer; 2003 Jun; 88(11):1746-54. PubMed ID: 12771991
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PAX8 Expression in well-differentiated pancreatic endocrine tumors: correlation with clinicopathologic features and comparison with gastrointestinal and pulmonary carcinoid tumors.
    Long KB; Srivastava A; Hirsch MS; Hornick JL
    Am J Surg Pathol; 2010 May; 34(5):723-9. PubMed ID: 20414099
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pheochromocytoma--pathohistologic and immunohistochemical aspects].
    Tatić S; Havelka M; Paunović I; Bozić V; Diklic A; Brasanac D; Janković R; Jancić-Zguricas M
    Srp Arh Celok Lek; 2002 Jul; 130 Suppl 2():7-13. PubMed ID: 12584991
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytokeratin 7 and 20 and thyroid transcription factor 1 can help distinguish pulmonary from gastrointestinal carcinoid and pancreatic endocrine tumors.
    Cai YC; Banner B; Glickman J; Odze RD
    Hum Pathol; 2001 Oct; 32(10):1087-93. PubMed ID: 11679943
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurofilament and chromogranin expression in normal and neoplastic neuroendocrine cells of the human gastrointestinal tract and pancreas.
    Perez MA; Saul SH; Trojanowski JQ
    Cancer; 1990 Mar; 65(5):1219-27. PubMed ID: 1689211
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Progesterone receptor immunoreactivity in pancreatic endocrine tumors. An immunocytochemical study of 156 neuroendocrine tumors of the pancreas, gastrointestinal and respiratory tracts, and skin.
    Viale G; Doglioni C; Gambacorta M; Zamboni G; Coggi G; Bordi C
    Cancer; 1992 Nov; 70(9):2268-77. PubMed ID: 1356613
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunohistochemical distribution of chromogranins A and B and secretogranin II in neuroendocrine tumours of the gastrointestinal tract.
    Fahrenkamp AG; Wibbeke C; Winde G; Ofner D; Böcker W; Fischer-Colbrie R; Schmid KW
    Virchows Arch; 1995; 426(4):361-7. PubMed ID: 7599788
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gastroenteropancreatic neuroendocrine tumors. A histochemical and immunohistochemical study of epithelial (keratin proteins, carcinoembryonic antigen) and neuroendocrine (neuron-specific enolase, bombesin and chromogranin) markers in foregut, midgut, and hindgut tumors.
    Nash SV; Said JW
    Am J Clin Pathol; 1986 Oct; 86(4):415-22. PubMed ID: 2429541
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Measurements of chromogranin A, chromogranin B (secretogranin I), chromogranin C (secretogranin II) and pancreastatin in plasma and urine from patients with carcinoid tumours and endocrine pancreatic tumours.
    Stridsberg M; Oberg K; Li Q; Engström U; Lundqvist G
    J Endocrinol; 1995 Jan; 144(1):49-59. PubMed ID: 7891024
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic usefulness of sustentacular cells in paragangliomas: immunocytochemical and ultrastructural investigation.
    Min KW
    Ultrastruct Pathol; 1998; 22(5):369-76. PubMed ID: 9887479
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current diagnosis and treatment of gastrointestinal carcinoids in a series of 101 patients: the significance of serum chromogranin-A, somatostatin receptor scintigraphy and somatostatin analogues.
    Nikou GC; Lygidakis NJ; Toubanakis C; Pavlatos S; Tseleni-Balafouta S; Giannatou E; Mallas E; Safioleas M
    Hepatogastroenterology; 2005; 52(63):731-41. PubMed ID: 15966194
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PCSK2 expression in neuroendocrine tumors points to a midgut, pulmonary, or pheochromocytoma-paraganglioma origin.
    Remes SM; Leijon H; Vesterinen T; Louhimo J; Pulkkinen V; Ezer S; Kere J; Haglund C; Arola J
    APMIS; 2020 Nov; 128(11):563-572. PubMed ID: 32794589
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Carcinoids of the gastrointestinal tract: importance of determining differentiation and proliferation markers].
    Jirásek T; Mandys V
    Cesk Patol; 2003 Apr; 39(2):47-53. PubMed ID: 12874899
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IMP3, NESP55, TTF-1 and CDX2 serve as an immunohistochemical panel in the distinction among small-cell carcinoma, gastrointestinal carcinoid, and pancreatic endocrine tumor metastasized to the liver.
    Denby KS; Briones AJ; Bourne PA; Spaulding BO; Lu D; Fischer-Colbrie R; Qu Z; Wang HL; Xu H
    Appl Immunohistochem Mol Morphol; 2012 Dec; 20(6):573-9. PubMed ID: 22495359
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chromogranins--new sensitive markers for neuroendocrine tumors.
    Eriksson B; Arnberg H; Oberg K; Hellman U; Lundqvist G; Wernstedt C; Wilander E
    Acta Oncol; 1989; 28(3):325-9. PubMed ID: 2545231
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Importance of vesicle proteins in the diagnosis and treatment of neuroendocrine tumors.
    Nilsson O; Jakobsen AM; Kölby L; Bernhardt P; Forssell-Aronsson E; Ahlman H
    Ann N Y Acad Sci; 2004 Apr; 1014():280-3. PubMed ID: 15153446
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Localization of carcinoids and pheochromocytomas with vein catheterization and amine determination.
    Nobin A; Karp W; Lunderquist A; Rosengren E; Sandén G; Sundler F
    Brain Res Bull; 1982; 9(1-6):781-97. PubMed ID: 7172048
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.